In this article, we explain why medical treatment may be recommended after a hair transplant and what can happen if the underlying hair loss is left untreated.

A hair transplant can be an effective option for appropriately selected patients with certain forms of alopecia. When the procedure is correctly indicated, carefully planned and followed by appropriate postoperative care, it can produce a significant and natural-looking improvement.

However, the final result does not appear immediately. Transplanted hairs typically go through several phases before the definitive outcome becomes apparent over the following months.

As Dr David Saceda, a specialist in Grupo Pedro Jaén’s Hair Disorders and Hair Transplant Unit, explains, postoperative care and long-term management of the underlying alopecia are important factors in maintaining the best possible result.

Before a hair transplant

The pattern of hair loss varies according to the type of alopecia. In androgenetic alopecia, hair loss may be more clearly defined around the temples or crown, particularly in men, or it may be more diffuse, as can occur in both men and women.

For surgical planning purposes, several areas can be distinguished:

Area of established hair loss

This is an area where hair was previously present but has now been largely or completely lost. A greater number of follicular units may need to be transplanted into this area to restore coverage. Careful surgical planning is required to determine the area to be treated and the density that can realistically be achieved.

Transition area

This area still contains the patient’s own hair, but the follicles are affected by miniaturisation. The hair shafts gradually become finer and scalp visibility may increase even though complete baldness has not developed. Transplanted follicular units may be placed among these existing hairs when appropriate in order to achieve a natural transition in density.

Currently unaffected area at risk of future hair loss

Some areas may still appear unaffected but lie within a pattern that could become involved in androgenetic alopecia over time. Predicting future progression is more difficult in younger patients. Transplanting directly into areas with a high density of healthy native follicles may not always be appropriate, as surgery must be planned carefully to avoid unnecessary damage and preserve options for the future.

Hair after a hair transplant

After a hair transplant, the recipient area may contain two main types of hair: transplanted hair and native hair that remains susceptible to the underlying alopecia. Transplanted follicular units are usually taken from a donor area at the back and sides of the scalp. In patients with androgenetic alopecia, follicles from these areas tend to be more resistant to androgen-related miniaturisation.

For this reason, transplanted hairs usually retain much of the biological behaviour of the donor area and can remain for many years. However, no hair can be guaranteed to remain unchanged for life in every patient, as ageing, donor-area characteristics and other medical factors may still influence long-term density.

The transplanted hairs are placed among existing native hairs to achieve the most natural-looking result possible.

The important distinction is that the hair transplant does not stop the underlying alopecia. Native hairs that were already susceptible to miniaturisation before surgery may continue to thin over time if the disease progresses.

What happens if I do not have medical treatment after a hair transplant?

The transplanted follicles may remain relatively resistant to the mechanisms driving androgenetic alopecia, while the surrounding non-transplanted hair can continue to miniaturise. If the underlying alopecia progresses without medical treatment, overall density may therefore decrease over time.

This can sometimes create an uneven appearance, with transplanted hair remaining in one area while adjacent native hair becomes progressively thinner. For example, a patient may retain transplanted hair in the central crown while the surrounding untreated hair continues to recede. For this reason, patients should understand that the hormonal and genetic mechanisms responsible for androgenetic alopecia continue to affect susceptible native follicles after surgery. The need for treatment and how long it should continue must be individualised according to the patient’s age, pattern of hair loss, rate of progression, tolerance and treatment goals.

Benefits of medical treatment after a hair transplant

When medically indicated, treatment after a hair transplant may provide several benefits:

1. Help preserve native hair that remains in the transition area and other parts of the scalp susceptible to androgenetic alopecia.

2. Improve the calibre and density of miniaturised native hair in patients who respond to treatment.

3. Slow progression in other areas that have not yet developed marked hair loss but are part of the typical pattern of androgenetic alopecia.

Benefits of medical treatment after a hair transplant

Can I have more than one hair transplant?

Yes, some patients undergo more than one hair transplant during their lifetime. However, hair transplantation cannot be repeated indefinitely.

The donor area contains a limited number of follicular units that can be safely harvested. When a follicular unit is removed from the donor area and transplanted elsewhere, a new follicle does not grow in its place. For this reason, donor management is an essential part of long-term surgical planning. As Dr Saceda explains, the donor area should not be overharvested: the surgeon must balance the number of follicular units removed with those left in place to preserve an acceptable density and appearance.

Further procedures may be possible when sufficient donor hair remains, but they should be planned with the likely future progression of the alopecia in mind.

It is also important to remember that hair transplantation is a surgical procedure. Although complications are uncommon when it is appropriately performed, there are still potential risks, and each procedure also involves recovery, cost and the use of additional donor follicles.

What is the best medical treatment after a hair transplant?

There is no single treatment that is appropriate for every patient. At Grupo Pedro Jaén’s Hair Disorders and Hair Transplant Unit, treatment is personalised according to the diagnosis, stage of alopecia, patient characteristics and evolution over time.

For some patients, topical treatment may be sufficient. Others may benefit from oral medication, and in selected cases several treatment options may be combined. Depending on the patient, these may include treatments such as minoxidil, finasteride or dutasteride, among other approaches, always taking into account their indications, contraindications and potential adverse effects. The objective is not simply to protect the transplanted hair, but to manage the underlying hair disorder and preserve as much native hair as possible over time.

If you have questions about the most appropriate medical treatment after a hair transplant, you can request an assessment at Grupo Pedro Jaén – Cinca in Madrid or Grupo Pedro Jaén – La Moraleja in Alcobendas.

Authorship and references

The content of this article has been prepared by the Grupo Pedro Jaén Communications Department and Medical Team in accordance with our editorial commitment, which ensures the accuracy and regular updating of the information provided.

References:

1. Manual de Tricología #TricoHRC. Directores: Sergio Vañó y Pedro Jaén. Comité editorial: Dr David Saceda y Dr Óscar Muñoz. ISBN: 978-84-09-05743-6.

2. Gupta AK, Bruce A, Trivellini R, Dua K, Mohebi P, True RH, Harris JA. Innovations hair restoration surgeons have made to adapt to the challenges of follicular unit excision. J Cosmet Dermatol. 2020 Aug;19(8):1883-1891.

3. Avram MR, Watkins S. Robotic Hair Transplantation. Facial Plast Surg Clin North Am. 2020 May;28(2):189-196. doi: 10.1016/j.fsc.2020.01.011.

4. Epstein GK, Epstein J, Nikolic J. Follicular Unit Excision: Current Practice and Future Developments. Facial Plast Surg Clin North Am. 2020 May;28(2):169-176. doi: 10.1016/j.fsc.2020.01.006.

5. Vañó Galván S. Hair Transplant: Added Value When Performed by a Dermatologist. Actas Dermosifiliogr. 2017 Jul-Aug;108(6):495-497. doi: 10.1016/j.ad.2017.06.001.

6. Vañó-Galván S, Villodres E, Pigem R, Navarro-Belmonte MR, Asín-Llorca M, Meyer-González T, Rodrigues-Barata R, Moreno-Arrones ÓM, Saceda-Corralo D, Bouhanna P, Camps A. Hair transplant in frontal fibrosing alopecia: A multicenter review of 51 patients. J Am Acad Dermatol. 2019 Sep;81(3):865-866. doi: 10.1016/j.jaad.2019.05.031.

7. Vañó-Galván S, Camacho F. New Treatments for Hair Loss. Actas Dermosifiliogr. 2017 Apr;108(3):221-228. doi: 10.1016/j.ad.2016.11.010.

8. Shanshanwal SJ, Dhurat RS. Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study. Indian J Dermatol Venereol Leprol. 2017 Jan-Feb;83(1):47-54.

9. Vañó-Galván S, Saceda-Corralo D, Moreno-Arrones OM, Rodrigues-Barata R, Morales C, Gil-Redondo R, Bernárdez-Guerra C, Hermosa-Gelbard Á, Jaén-Olasolo P. Effectiveness and safety of oral dutasteride for male androgenetic alopecia in real clinical practice: A descriptive monocentric study. Dermatol Ther. 2020 Jan;33(1):e13182. doi: 10.1111/dth.13182.

10. Tsunemi Y, Irisawa R, Yoshiie H, Brotherton B, Ito H, Tsuboi R, Kawashima M, Manyak M; ARI114264 Study Group. Long-term safety and efficacy of dutasteride in the treatment of male patients with androgenetic alopecia. J Dermatol. 2016 Sep;43(9):1051-8.

11. Gubelin Harcha W, Barboza Martínez J, Tsai TF, Katsuoka K, Kawashima M, Tsuboi R, Barnes A, Ferron-Brady G, Chetty D. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia. J Am Acad Dermatol. 2014 Mar;70(3):489-498.e3.

12. Saceda-Corralo D, Rodrigues-Barata AR, Vano-Galvan S, Jaen-Olasolo P. Mesotherapy with dutasteride in the treatment of androgenetic alopecia. Int J Trichol. 2017;9:143-5.

13. Jimenez-Cauhe J, Saceda-Corralo D, Rodrigues-Barata R, Hermosa-Gelbard A, Moreno-Arrones OM, Fernandez-Nieto D, Vaño-Galvan S. Effectiveness and safety of low-dose oral minoxidil in male androgenetic alopecia. J Am Acad Dermatol. 2019 Aug;81(2):648-649.

14. Jimenez-Cauhe J, Saceda-Corralo D, Rodrigues-Barata R, Moreno-Arrones OM, Ortega-Quijano D, Fernandez-Nieto D, Jaen-Olasolo P, Vaño-Galvan S. Safety of low-dose oral minoxidil treatment for hair loss. A systematic review and pooled-analysis of individual patient data. Dermatol Ther. 2020 Aug 5. doi: 10.1111/dth.14106.

15. Martinez-Jacobo L, Villarreal-Villarreal CD, Ortiz-López R, Ocampo-Candiani J, Rojas-Martínez A. Genetic and molecular aspects of androgenetic alopecia. Indian J Dermatol Venereol Leprol. 2018 May-Jun;84(3):263-268. doi: 10.4103/ijdvl.IJDVL_262_17. PMID: 29595184.